Sp391

PANEL DISCUSSION

Date
May 7, 2023
Explore related products in the following collection:

Society: AGA

The purpose of this session is to provide early career and trainee gastroenterologist with tips and strategies for having successful first few years in clinical practice. This session will discuss topics that are pertinent to all gastroenterologists including medical-legal issues (standardization of care, litigation, best practice), navigating difficult conversations, and tips that are specific to the various GI practice types. Attendees will receive high-yield and relevant information from respected AGA leaders in a format that is interactive and engaging.

Presenters

Speaker Image for Folasade (Fola) May
University of California Los Angeles; Veterans Affairs

Tracks

Related Products

Thumbnail for LONG-TERM SAFETY OF 3 YEARS OF OZANIMOD IN MODERATELY TO SEVERELY ACTIVE ULCERATIVE COLITIS: AN INTERIM ANALYSIS OF THE TRUE NORTH OPEN-LABEL EXTENSION
LONG-TERM SAFETY OF 3 YEARS OF OZANIMOD IN MODERATELY TO SEVERELY ACTIVE ULCERATIVE COLITIS: AN INTERIM ANALYSIS OF THE TRUE NORTH OPEN-LABEL EXTENSION
BACKGROUND AND AIMS: A treat-to-target (TTT) strategy of striving for symptomatic and endoscopic remission is recommended for the management of inflammatory bowel diseases (IBD). Yet, real-world uptake of TTT strategies has been modest…
Thumbnail for STATE-OF-THE-ART: CAN WE MOVE THE NEEDLE IN CRC SCREENING IN UNDER REPRESENTED MINORITIES
STATE-OF-THE-ART: CAN WE MOVE THE NEEDLE IN CRC SCREENING IN UNDER REPRESENTED MINORITIES
BACKGROUND: Although colorectal cancer (CRC) screening has been recommended for decades, about one-third of eligible individuals are not up-to-date with screening in the US. The COVID-19 pandemic has worsened this situation…
Thumbnail for IMPACT OF STATE MEDICAID EXPANSION STATUS ON COLORECTAL CANCER SCREENING RATES AND PREDICTORS OF SCREENING AT U.S. FEDERALLY QUALIFIED HEALTH CENTERS
IMPACT OF STATE MEDICAID EXPANSION STATUS ON COLORECTAL CANCER SCREENING RATES AND PREDICTORS OF SCREENING AT U.S. FEDERALLY QUALIFIED HEALTH CENTERS
BACKGROUND: Although colorectal cancer (CRC) screening has been recommended for decades, about one-third of eligible individuals are not up-to-date with screening in the US. The COVID-19 pandemic has worsened this situation…
Thumbnail for COLORECTAL CANCER SCREENING RATES AT FEDERALLY QUALIFIED HEALTH CENTERS IN THE UNITED STATES FROM 2020 TO 2021: INCOMPLETE REBOUND AND WORSENING DISPARITIES
COLORECTAL CANCER SCREENING RATES AT FEDERALLY QUALIFIED HEALTH CENTERS IN THE UNITED STATES FROM 2020 TO 2021: INCOMPLETE REBOUND AND WORSENING DISPARITIES
BACKGROUND: Although colorectal cancer (CRC) screening has been recommended for decades, about one-third of eligible individuals are not up-to-date with screening in the US. The COVID-19 pandemic has worsened this situation…